IP Verse

Method For Predicting The Off-Target Biding Of A Peptide Which Binds To A Target Peptide Presented By A Major Histocompatibility Complex

EP2936158

ADAPTIMMUNE LIMITED
Application Number
EP13811256A
Filing Date
Dec 17, 2013
Status
Revoked
Nov 5, 2021
Grant Date
Feb 13, 2019
External Links
Slate, Register

Biblio Summary

The patent EP2936158B1 was granted on Feb 13, 2019 by Adaptimmune Limited The patent is currently Revoked.

Oppositions Filed by other Companies on the Patent

The table below shows 3 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

SCHIWECK WEINZIERL KOCH PATENTANWALTE PARTNERSCHAFT MBBNov 13, 2019ADMISSIBLE
GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT MBHNov 12, 2019ADMISSIBLE
MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBBFeb 15, 2019ADMISSIBLE

More Opposed Patents of Adaptimmune Limited

The table below shows the patents of Adaptimmune Limited that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3373013Method For Predicting The Off-Target Biding Of A Peptide Which Binds To A Target Peptide Presented By A Major Histocompatibility ComplexJul 19, 20233
EP3440104T Cell ReceptorsJun 14, 20231
EP3060668Vectors For Transgene ExpressionOct 19, 20221

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.

  • Date

    Description

  • Get instant alerts for new documents